Abstract:BACKGROUND Esophageal squamous cell carcinoma (ESCC) is a malignant tumor with high morbidity and mortality, and easy to develop resistance to chemotherapeutic agents. Telomeres are DNA-protein complexes located at the termini of chromosomes in eukaryotic cells, which are unreplaceable in maintaining the stability and integrity of genome. Telomerase, an RNA-dependent DNA polymerase, play vital role in telomere length maintain, targeting telomerase is a promising therapeutic strategy for cancer. AIM To investigate the efficacy and underlying mechanisms of BIBR1532, a telomerase inhibitor, in ESCC. METHODS KYSE150 and KYSE410 cells were cultured and exposed to various concentrations of BIBR1532. Cell viability was assessed at 48 hours and 72 hours to determine the IC50 values. The effects of BIBR1532 on ESCC cell proliferation, migration, and cellular senescence were evaluated using the cell counting kit-8 assay, plate colony formation assay, scratch assay, transwell assay, and β-galactosidase staining, respectively. Western blotting was performed to detect the expression of proteins in BIBR1532-treated ESCC cells, such as human telomerase reverse transcriptase (hTERT), key molecules involved in DNA damage response (DDR) or cellular senescence, as well as telomere-binding proteins. Additionally, a tumor-bearing nude mouse model was established to evaluate the anti-cancer effect of BIBR1532 in vivo . RESULTS The IC50 values for KYSE150 and KYSE410 cells after 48 hours of BIBR1532 exposure were 48.53 μM and 39.59 μM, respectively. These values decreased to 37.22 μM and 22.71 μM, respectively, following a longer exposure of 72 hours. BIBR1532 exhibited dose-dependent effects on KYSE150 and KYSE410 cells, including decreased hTERT expression, inhibition of proliferation and metastasis, and induction of cellular senescence. Mechanistically, BIBR1532 upregulated the expression of the DDR protein, γ-H2AX, and activated the ataxia telangiectasia and Rad3-related protein (ATR)/ check point kinase 1 (CHK-1) and ataxia-telangiectasia mutated gene (ATM)/CHK2 pathways. BIBR1532 downregulated the expression of telomere-binding proteins, including telomeric-repeat binding factor 1 (TRF1), TRF2, protection of telomeres 1, and TIN2-interacting protein 1. In a nude mouse xenograft model, BIBR1532 significantly suppressed tumor growth, reduced hTERT expression, and increased γ-H2AX protein levels. Hematoxylin and eosin staining of various organs, including the heart, liver, spleen, lungs, and kidneys, revealed no apparent adverse effects. CONCLUSION BIBR1532 exerts anti-cancer effects on ESCC by inducing DDR through the ATR/CHK1 and ATM/CHK2 pathways and downregulating the expression of telomere-binding proteins.

Growth Inhibition of BIBR1532 to Cancer Cells with P53 and Prb Inactivation

BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.

Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment

BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation

EFFECTS OF P53 ON GROWTH AND CYCLE RELATIVE GENES OF MCF-7 BREAST CANCER CELLS

Persistent P21 Expression after Nutlin-3a Removal is Associated with Senescence-Like Arrest in 4n Cells

Growth-inhibiting effects of toremifene combined with cisplatin on p53-deficient strain of human lung cancer H1299 cells

Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells

Inhibition of telomerase limits the growth of human cancer cells

P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

[The Molecular Interaction Between P53 and Telomeric Repeat Binding Protein 1 in Vitro].

BRCA1 inhibition of telomerase activity in cultured cells.

Telomerase Suppression Initiates PML-dependent P53 Activation to Inhibit Bladder Cancer Cell Growth

Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells

Radiosensitization Of Non-Small Cell Lung Cancer Cells By Inhibition Of Tgf-Beta 1 Signaling With Sb431542 Is Dependent On P53 Status

Inhibition of telomerase activity in salivary adenoid cystic carcinoma cells by P53

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

Cell Senescence and Its Critical Role in Antitumor Research

PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation